methyl 5-ethyl-6-methyl-2-pyridinecarboxylate | 153646-87-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: methyl 5-ethyl-6-methyl-2-pyridinecarboxylate
• 英文别名: Methyl 5-ethyl-6-methylpicolinate；methyl 5-ethyl-6-methylpyridine-2-carboxylate
• CAS: 153646-87-8
• 化学式: C₁₀H₁₃NO₂
• 分子量: 179.219
• InChiKey: OBQMYFHUAVTSOC-UHFFFAOYSA-N

物化性质

• 沸点：
  293.7±28.0 °C(Predicted)
• 密度：
  1.056±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  methyl 5-ethyl-6-methyl-2-pyridinecarboxylate 在 二异丁基氢化铝 作用下， 以 二氯甲烷 为溶剂， 生成 (5-ethyl-6-methylpyridin-2-yl)methanol
  参考文献：
  名称：

  A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®

  摘要：

  The structure-activity relationship of a series of styrylpyridine analogs of MK-0476 (montelukast, Singulair(R)) is described. This work has led to the identification of a number of potent and orally active cysLT(1), receptor (LTD4 receptor) antagonists including 2ab (1,-733,321) as an optimized candidate. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00051-1
• 作为产物：
  描述：

  3-ethyl-2-methylpyridine1-oxide 在 盐酸 、 N,N-二乙基氯甲酰胺 作用下， 以 1,2-二氯乙烷 为溶剂， 生成 methyl 5-ethyl-6-methyl-2-pyridinecarboxylate
  参考文献：
  名称：

  A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®

  摘要：

  The structure-activity relationship of a series of styrylpyridine analogs of MK-0476 (montelukast, Singulair(R)) is described. This work has led to the identification of a number of potent and orally active cysLT(1), receptor (LTD4 receptor) antagonists including 2ab (1,-733,321) as an optimized candidate. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00051-1

文献信息

• Pyridine-substituted benzyl alcohols as leukotriene antagonists
  申请人：Merck Frosst Canada, Inc.

  公开号：US05506227A1

  公开（公告）日：1996-04-09

  Compounds having the formula I: ##STR1## are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.

  具有公式I的化合物：##STR1## 是白三烯作用的拮抗剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还可用于治疗心绞痛、脑血管痉挛、肾小球肾炎、肝炎、内毒素血症、葡萄膜炎和移植排斥反应。
• US5506227A
  申请人：——

  公开号：US5506227A

  公开（公告）日：1996-04-09
• [EN] PYRIDINE-SUBSTITUTED BENZYL ALCOHOLS AS LEUKOTRIENE ANTAGONISTS<br/>[FR] ALCOOLS BENZYLIQUES SUBSTITUES PAR PYRIDINE EN TANT QU'ANTAGONISTES DES LEUCOTRIENES
  申请人：MERCK FROSST CANADA INC.

  公开号：WO1993021158A1

  公开（公告）日：1993-10-28

  (EN) Compounds having formula (I) are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.(FR) Des composés selon la formule (I) sont des antagonistes des actions des leucotriènes. Ces composés sont utiles en tant qu'agents antiasthmatiques, antiallergiques, anti-inflammatoires et cytoprotecteurs. Ils sont également utiles dans le traitement de l'angine du spasme cérébral, de la néphrite glomérulaire, de l'hépatite, de l'endotoxémie, de l'uvéite et du rejet allogreffe.
• A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®
  作者：Daniel Guay、J.Y. Gauthier、C. Dufresne、T.R. Jones、M. McAuliffe、C. McFarlane、K.M. Metters、P. Prasit、C. Rochette、P. Roy、N. Sawyer、R. Zamboni

  DOI：10.1016/s0960-894x(98)00051-1

  日期：1998.3

  The structure-activity relationship of a series of styrylpyridine analogs of MK-0476 (montelukast, Singulair(R)) is described. This work has led to the identification of a number of potent and orally active cysLT(1), receptor (LTD4 receptor) antagonists including 2ab (1,-733,321) as an optimized candidate. (C) 1998 Elsevier Science Ltd. All rights reserved.